Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis

By afschroeder • June 25, 2025

Todd JL, Page C, Wu P, Belperio JA, Maher TM, Palmer SM, Leonard TB, Hesslinger C, Neely ML, Schlange T. Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosis. ERJ Open Res. 2025 Jun 23;11(3):00738-2024. doi: 10.1183/23120541.00738-2024. PMID: 40551789; PMCID: PMC12183712.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O2 therapy

Adami A, Vitacca M, Casaburi R, Salvi B, Simonelli C, Rossiter HB, Paneroni M. Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by[...]

Mechanomedicine

Liu Z, Chen G, Jo MS, Vogel V, Chen J, Rogers JA, Li S. Mechanomedicine. Nat Rev Bioeng. 2026 Mar;4(3):216-235. doi: 10.1038/s44222-025-00391-6. Epub 2026 Jan[...]

Lupus Erythematosus Tumidus Mimicking Erythema Nodosum: A Diagnostic Challenge

Aung T, Eblen K, Pierce J, Gates G. Lupus Erythematosus Tumidus Mimicking Erythema Nodosum: A Diagnostic Challenge. Cureus. 2026 Mar 3;18(3):e104616. doi: 10.7759/cureus.104616. PMID: 41939593;[...]